Showcasing Preclinical Promise of Targeting TDP-43 in Alzheimer’s Disease
Time: 2:30 pm
day: Conference Day Two - Track Two
Details:
- Reviewing why targeting TDP-43 has historically been difficult
- Outlining the mechanisms of the small molecule to directly target TDP-43
- Characterizing the animal efficacy data
- Discussing TDP-43 prevalence in AD and future directions for clinical translation of this target
